Conditions: Schizophrenia
Keywords: Aripiprazole Deltoid
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 17
Healthy volunteers: no

Brief summary:
To assess the pharmacokinetics and safety of aripiprazole intra-muscular (IM) depot formulation in patients with schizophrenia after repeated administration by injection into the deltoid muscle for a total of 5 doses of 400 mg in 4-week intervals

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: OPC-14597 IMD
Intervention descriptions: intervention 1: Administration by injection into the deltoid muscle for a total of 5 doses of 400 mg in 4-week intervals

Protocol document: